Smithfield Trust’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $80K | Hold |
272
| – | – | ﹤0.01% | 528 |
|
|
2025
Q4 | $97K | Hold |
272
| – | – | ﹤0.01% | 478 |
|
|
2025
Q3 | $89K | Sell |
272
-153
| -36% | -$47.6K | ﹤0.01% | 481 |
|
|
2025
Q2 | $167K | Hold |
425
| – | – | 0.01% | 368 |
|
|
2025
Q1 | $183K | Buy |
425
+37
| +10% | +$14.9K | 0.01% | 351 |
|
|
2024
Q4 | $143K | Buy |
388
+5
| +1% | +$2.09K | 0.01% | 391 |
|
|
2024
Q3 | $201K | Hold |
383
| – | – | 0.01% | 341 |
|
|
2024
Q2 | $207K | Hold |
383
| – | – | 0.01% | 324 |
|
|
2024
Q1 | $201K | Hold |
383
| – | – | 0.01% | 330 |
|
|
2023
Q4 | $180K | Sell |
383
-292
| -43% | -$135K | 0.01% | 329 |
|
|
2023
Q3 | $293K | Sell |
675
-10
| -1% | -$4.54K | 0.02% | 243 |
|
|
2023
Q2 | $303K | Sell |
685
-26
| -4% | -$12K | 0.02% | 248 |
|
|
2023
Q1 | $330K | Buy |
711
+380
| +115% | +$181K | 0.02% | 238 |
|
|
2022
Q4 | $170K | Sell |
331
-28
| -8% | -$14.2K | 0.01% | 315 |
|
|
2022
Q3 | $165K | Sell |
359
-118
| -25% | -$56.5K | 0.01% | 306 |
|
|
2022
Q2 | $230K | Sell |
477
-24
| -5% | -$11.9K | 0.02% | 264 |
|
|
2022
Q1 | $244K | Buy |
501
+198
| +65% | +$90.5K | 0.02% | 274 |
|
|
2021
Q4 | $141K | Hold |
303
| – | – | 0.01% | 386 |
|
|
2021
Q3 | $113K | Hold |
303
| – | – | 0.01% | 412 |
|
|
2021
Q2 | $115K | Hold |
303
| – | – | 0.01% | 412 |
|
|
2021
Q1 | $108K | Buy |
303
+15
| +5% | +$4.82K | 0.01% | 427 |
|
|
2020
Q4 | $92K | Buy |
288
+37
| +15% | +$11.4K | 0.01% | 440 |
|
|
2020
Q3 | $67K | Buy |
251
+29
| +13% | +$7.8K | 0.01% | 455 |
|
|
2020
Q2 | $58K | Buy |
222
+157
| +242% | +$41.9K | 0.01% | 465 |
|
|
2020
Q1 | $14K | Hold |
65
| – | – | ﹤0.01% | 628 |
|
|
2019
Q4 | $19K | Hold |
65
| – | – | ﹤0.01% | 628 |
|
|
2019
Q3 | $16K | Hold |
65
| – | – | ﹤0.01% | 677 |
|
|
2019
Q2 | $18K | Hold |
65
| – | – | ﹤0.01% | 643 |
|
|
2019
Q1 | $19K | Hold |
65
| – | – | ﹤0.01% | 594 |
|
|
2018
Q4 | $17K | Hold |
65
| – | – | ﹤0.01% | 593 |
|
|
2018
Q3 | $18K | Hold |
65
| – | – | ﹤0.01% | 654 |
|
|
2018
Q2 | $16K | Hold |
65
| – | – | ﹤0.01% | 676 |
|
|
2018
Q1 | $14K | Hold |
65
| – | – | ﹤0.01% | 672 |
|
|
2017
Q4 | $14K | Buy |
+65
| New | +$13.8K | ﹤0.01% | 704 |
|
|
2015
Q4 | – | Sell |
-248
| Closed | -$35K | – | 835 |
|
|
2015
Q3 | $35K | Hold |
248
| – | – | 0.01% | 533 |
|
|
2015
Q2 | $41K | Sell |
248
-42
| -14% | -$6.71K | 0.01% | 542 |
|
|
2015
Q1 | $45K | Hold |
290
| – | – | 0.01% | 536 |
|
|
2014
Q4 | $36K | Hold |
290
| – | – | 0.01% | 552 |
|
|
2014
Q3 | $35K | Hold |
290
| – | – | 0.01% | 568 |
|
|
2014
Q2 | $32K | Buy |
290
+70
| +32% | +$7.21K | 0.01% | 597 |
|
|
2014
Q1 | $22K | Hold |
220
| – | – | ﹤0.01% | 622 |
|
|
2013
Q4 | $20K | Hold |
220
| – | – | ﹤0.01% | 621 |
|
|
2013
Q3 | $18K | Hold |
220
| – | – | ﹤0.01% | 601 |
|
|
2013
Q2 | $18K | Buy |
+220
| New | +$16.5K | ﹤0.01% | 589 |
|
Other funds holding ELV
VCM
VPM
Smithfield Trust's ELV Position: Q1 2026 in Review
Smithfield Trust held its Elevance Health (ELV) position steady in Q1 2026 at 272 shares worth $80K. The position accounts for ﹤0.01% of the portfolio, ranked #528.
Smithfield Trust first reported a position in ELV in Q2 2013 and has held it in 44 quarters since. The position peaked at $330K in Q1 2023. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Smithfield Trust held 272 shares of Elevance Health worth $80K as of Q1 2026.
- Smithfield Trust left its Elevance Health share count unchanged in Q1 2026.
- Elevance Health made up ﹤0.01% of Smithfield Trust's portfolio in Q1 2026, its #528 holding.
- Smithfield Trust first reported a position in Elevance Health in Q2 2013 and has held it in 44 quarters since.
- Smithfield Trust's Elevance Health position peaked at $330K in Q1 2023.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Smithfield Trust's 13F filing for Q1 2026, filed 8 May 2026.